Acorah Software Products - Accounts Production 19.4.300 false true 31 January 2025 1 February 2024 false 1 February 2025 31 January 2026 31 January 2026 13831332 Dr Yupu Lin iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 13831332 2025-01-31 13831332 2026-01-31 13831332 2025-02-01 2026-01-31 13831332 frs-core:CurrentFinancialInstruments 2026-01-31 13831332 frs-core:ShareCapital 2026-01-31 13831332 frs-core:RetainedEarningsAccumulatedLosses 2026-01-31 13831332 frs-bus:PrivateLimitedCompanyLtd 2025-02-01 2026-01-31 13831332 frs-bus:FilletedAccounts 2025-02-01 2026-01-31 13831332 frs-bus:SmallEntities 2025-02-01 2026-01-31 13831332 frs-bus:AuditExempt-NoAccountantsReport 2025-02-01 2026-01-31 13831332 frs-bus:SmallCompaniesRegimeForAccounts 2025-02-01 2026-01-31 13831332 frs-bus:Director1 2025-02-01 2026-01-31 13831332 frs-countries:EnglandWales 2025-02-01 2026-01-31 13831332 2024-01-31 13831332 2025-01-31 13831332 2024-02-01 2025-01-31 13831332 frs-core:CurrentFinancialInstruments 2025-01-31 13831332 frs-core:ShareCapital 2025-01-31 13831332 frs-core:RetainedEarningsAccumulatedLosses 2025-01-31
Registered number: 13831332
Euphrosyne Investment Limited
Unaudited Financial Statements
For The Year Ended 31 January 2026
Brookwood Accountancy Limited
Contents
Page
Balance Sheet 1
Notes to the Financial Statements 2
Page 1
Balance Sheet
Registered number: 13831332
2026 2025
Notes £ £ £ £
CURRENT ASSETS
Debtors 4 711,095 720,095
Cash at bank and in hand 7 10,043
711,102 730,138
Creditors: Amounts Falling Due Within One Year 5 (713,538 ) (731,882 )
NET CURRENT ASSETS (LIABILITIES) (2,436 ) (1,744 )
TOTAL ASSETS LESS CURRENT LIABILITIES (2,436 ) (1,744 )
NET LIABILITIES (2,436 ) (1,744 )
CAPITAL AND RESERVES
Called up share capital 6 100 100
Profit and Loss Account (2,536 ) (1,844 )
SHAREHOLDERS' FUNDS (2,436) (1,744)
For the year ending 31 January 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
Dr Yupu Lin
Director
14/10/2026
The notes on page 2 form part of these financial statements.
Page 1
Page 2
Notes to the Financial Statements
1. General Information
Euphrosyne Investment Limited is a private company, limited by shares, incorporated in England & Wales, registered number 13831332 . The registered office is Flat 7 Clarendon Court, 34 Grove Street, Oxford, OX2 7JJ.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
3. Average Number of Employees
Average number of employees, including directors, during the year was: NIL (2025: NIL)
- -
4. Debtors
2026 2025
£ £
Due within one year
Other debtors 711,000 720,000
Director's loan account 95 95
711,095 720,095
5. Creditors: Amounts Falling Due Within One Year
2026 2025
£ £
Other creditors 712,883 731,258
Accruals and deferred income 655 624
713,538 731,882
6. Share Capital
2026 2025
£ £
Allotted, Called up and fully paid 100 100
7. Related Party Transactions
A loan of £711,720 received from Epeius Realty Limited remains outstanding. This loan is repayable on demand. 
Epeius Realty LtdParent Company

Epeius Realty Ltd

Parent Company

Page 2